
Male, Urticaria, Histamine Antagonists, Disease Management, Omalizumab, Antibodies, Monoclonal, Humanized, Tacrolimus, Antibodies, Anti-Idiotypic, Autoimmune Diseases, Chronic Disease, Cyclosporine, Prevalence, Humans, Female, Immunosuppressive Agents
Male, Urticaria, Histamine Antagonists, Disease Management, Omalizumab, Antibodies, Monoclonal, Humanized, Tacrolimus, Antibodies, Anti-Idiotypic, Autoimmune Diseases, Chronic Disease, Cyclosporine, Prevalence, Humans, Female, Immunosuppressive Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
